Login / Signup

Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.

Jason D LickliterMark VoskoboynikLinda MileshkinHui K GanGanessan KichenadasseKathy ZhangMaggie ZhangZhiyu TangMichael Millward
Published in: British journal of cancer (2021)
NCT02361723.
Keyphrases
  • randomized controlled trial
  • clinical trial
  • human health
  • climate change